TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
With a market cap of 5.12B, TG Therapeutics(TGTX) trades at $32.51. The stock has a price-to-earnings ratio of 11.61.
On 2025-11-08, TG Therapeutics(TGTX) stock moved within a range of $31.99 to $33.50. With shares now at $32.51, the stock is trading +1.6% above its intraday low and -2.9% below the session's peak.
Trading activity shows a volume of 1.76M, compared to an average daily volume of 2.32M.
The stock's 52-week range extends from a low of $25.28 to a high of $46.48.
The stock's 52-week range extends from a low of $25.28 to a high of $46.48.
TGTX News
TG Therapeutics reported strong third quarter results in the past week, posting revenue of US$161.71 million and net income of US$390.9 million, and raising its...
TG Therapeutics ((TGTX)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks...